Blue Star Ltd (BLUESTARCO) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Blue Star Ltd on NSE and BSE, with an AI summary of each filing.
Please find enclosed
Others (Uncategorized) · 04 Nov 2026, 12:17 am
Blue Star Grants 6,520 Stock Options Under ESOP 2024 Scheme Blue Star Limited's Nomination and Remuneration Committee approved the grant of 6,520 stock options to an eligible employee under its ESOP 2024 scheme on 3rd Nov'26. Each option is convertible into one equity share of face value Rs 2 at an exercise price of Rs 2 per option. The options will vest in four equal tranches of 25% annually across 12, 24, 36, and 48 months, contingent on predefined performance criteria, with an exercise window of seven years from the grant date.
Please find enclosed.
Others (Uncategorized) · 01 Nov 2026, 1:28 am
Dubai Court of Appeal Dismisses Annulment Plea Against Blue Star's Arbitration Award The Dubai Court of Appeal has dismissed in entirety W.J. Towell & Co LLC's (WJT) application seeking annulment of an ICC arbitration award favoring Blue Star Limited. Previously, on 23rd Jul'26, the arbitrator had dismissed WJT's entire claim of OMR 2,11,80,748 (~Rs 461.74 crore) regarding their Blue Star Oman Electro Mechanical Company joint venture. Blue Star maintains that WJT's claims are baseless and confirmed that any further appeals by WJT will be contested for dismissal, resulting in nil financial liability for the company.
Please find enclosed
Others (Uncategorized) · 31 Oct 2026, 3:13 am
Blue Star Q2FY27 Results: Revenue Up 21% YoY, Net Cash Position Achieved Blue Star reported a 21.0% YoY increase in Q2FY27 consolidated revenue from operations to ₹2,931 cr. Operating profit (EBITDA) improved 10.5% YoY to ₹203 cr with a 6.9% margin, while PBT before JV share and exceptional items rose to ₹134 cr from ₹133 cr in Q2FY26. The company recorded an exceptional gain of ₹23.02 cr from the slump sale of Blue Star E&E’s MedTech business effective 31st Aug'26. Carried-forward order book reached ₹7,229 cr as of Sep'26, shifting to net cash of ₹289.43 cr.
Please find enclosed
Audio / Video · 30 Oct 2026, 11:33 pm
Blue Star Releases Q2 and H1 Earnings Call Audio Recording Blue Star Limited has made available the audio recording of its Investors' Conference Call for the second quarter and half year ended 30th Sep'26. In compliance with Regulations 30 and 46 of SEBI LODR Regulations, the company hosted the recording on its official website following the scheduled earnings discussion.
Please find enclosed
Investor Presentation · 30 Oct 2026, 10:22 pm
Blue Star Reports Strong Q2FY27 Revenue Growth Amid Segmental Margin Pressures Blue Star delivered Q2FY27 revenue from operations of ₹2,930.95 cr, up 21.0% YoY, while EBITDA grew 10.5% YoY to ₹202.58 cr. Net profit rose 25.4% YoY to ₹123.91 cr, supported by a ₹23.02 cr exceptional gain from divesting the MedTech business on 31st Aug'26. Segmentally, Unitary Products revenue expanded 29.4% YoY on extended summer demand, though EBIT margins contracted 390 bps to 2.3% due to unabsorbed material cost escalations. The carried-forward order book stood at ₹7,229.22 cr as of 30th Sep'26.
Please find enclosed
Others (Uncategorized) · 30 Oct 2026, 4:56 pm
Blue Star Q2FY27 Results: Net Profit Jumps 25.4% Despite Margin Compression Blue Star reported a 21.0% YoY revenue increase to ₹2,930.95 cr in Q2FY27, driven by strong Room AC demand from an extended summer. Net profit surged 25.4% YoY to ₹123.91 cr, while EBITDA grew to ₹202.58 cr, though EBITDA margin contracted 70 bps YoY to 6.9% due to elevated material costs. The carried-forward order book reached ₹7,229.22 cr as of 30th Sep'26. Balance sheet strength improved significantly, shifting to a net cash position of ₹289.43 cr versus net borrowings of ₹417.06 cr a year ago.
Please find enclosed
Investor Presentation · 30 Oct 2026, 4:52 pm
Blue Star Reports Strong Q2FY27 Revenue Growth Driven by Unitary Products Blue Star delivered Q2FY27 consolidated revenue of ₹2,930.95 cr, up 21.0% YoY, supported by Unitary Products (+29.4% YoY) and Electro-Mechanical Projects (+16.3% YoY). EBITDA climbed 10.5% YoY to ₹202.58 cr, while reported net profit rose 25.4% YoY to ₹123.91 cr, aided by a ₹23.02 cr exceptional gain from divesting its MedTech business. Input cost escalations pressured margins across key cooling segments. The order book stood at ₹7,229.22 cr as of 30th Sep'26, while the balance sheet turned net cash positive at ₹289.43 cr.
Please find enclosed
Change in Management · 29 Oct 2026, 9:52 pm
Blue Star Appoints Key Senior Management Personnel Effective November 2026 Blue Star's Board of Directors approved the appointment of Nithianand S (Group President, Supply Chain & Procurement) and Senthil Thangam (President, Air Conditioning & Refrigeration Solutions Group) as Senior Management Personnel, effective 1st Nov'26. Nithianand, who joined in Mar'21, previously drove procurement savings and margin expansion in the Room AC business. Thangam, a company veteran since 1995 with over 30 years of experience, has led product management and commercial AC rollouts, including inverter VRF and centrifugal chillers.
Please find enclosed
Press Release · 29 Oct 2026, 9:51 pm
Blue Star Posts Q2FY27 Revenue Growth of 21% as Net Profit Jumps 25.4% For Q2 ended 30th Sep'26, Blue Star reported a 21.0% YoY rise in consolidated revenue to Rs 2,930.95 crore, driven by robust room AC demand during an extended summer. Operating profit increased 10.5% YoY to Rs 202.58 crore, though EBITDA margin contracted to 6.9% due to elevated input costs. Net profit rose 25.4% YoY to Rs 123.91 crore, aided by an exceptional gain of Rs 23.02 crore from divesting its MedTech business. Order book stood at Rs 7,229.22 crore, with net cash improving to Rs 289.43 crore.
Please find enclosed outcome of the Board Meeting
Outcome · 29 Oct 2026, 9:48 pm
Please find enclosed outcome of the Board Meeting
Outcome · 29 Oct 2026, 9:46 pm
Blue Star Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 29 Oct 2026, 9:46 pm
Please find enclosed outcome of the Board Meeting.
Financial Result · 29 Oct 2026, 9:43 pm
Blue Star Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 2,931 (+21.0% YoY | -13.2% QoQ) ■ EBITDA: 203 (+10.4% YoY | +15.8% QoQ) ■ EBITDA Margin (%): 6.9 (-66 bps YoY | +173 bps QoQ) ■ PAT: 124 (+25.2% YoY | +20.9% QoQ) ■ EPS (INR): 6.03 (+25.6% YoY | +20.8% QoQ) Blue Star Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) Segmental Performance Electro - mechanical projects and commercial air conditioning systems ■ Revenue: 1,936 (+16.3% YoY | +19.1% QoQ) ■ EBIT: 133 (-9.5% YoY | +20.8% QoQ) ■ EBIT Margin (%): 6.9 (-196 bps YoY | +10 bps QoQ) Unitary products ■ Revenue: 898 (+29.4% YoY | -46.9% QoQ) ■ EBIT: 20.7 (-51.5% YoY | -58.3% QoQ) ■ EBIT Margin (%): 2.3 (-385 bps YoY | -63 bps QoQ) Professional electronics and industrial systems ■ Revenue: 97.3 (+51.2% YoY | +53.1% QoQ) ■ EBIT: 23.1 (+274.4% YoY | +141.4% QoQ) ■ EBIT Margin (%): 23.7 (+1415 bps YoY | +868 bps QoQ)
Schedule of Conference Call for the Second Quarter and Half Year ended on September 30, 2026
Intimation · 30 Oct 2026, 11:30 am
Blue Star Schedules Q2 and H1-FY27 Earnings Conference Call Blue Star Limited will host an investors' conference call on 30th Oct'26 at 11:30 a.m. IST to discuss financial performance for the second quarter and half year ended 30th Sep'26 (Q2 & H1-FY27). Key management attendees include Managing Director B. Thiagarajan and Group Chief Financial Officer Nikhil Sohoni. Universal dial-in numbers are +91 22 6280 1102 and +91 22 7115 8003, with pre-registration available via DiamondPass. International toll-free access is available for the USA, UK, Singapore, Japan, Canada, and Hong Kong.
Please find enclosed intimation for voluntary strike off of Blue Star Air Conditioning (U) Limited, a step down subsidiary of the Company
Others (Uncategorized) · 15 Oct 2026, 1:16 am
Blue Star Approves Voluntary Strike-Off of Uganda Step-Down Subsidiary Blue Star International FZCO, a wholly owned subsidiary of Blue Star Limited, approved the voluntary strike-off of its Uganda-based step-down subsidiary, Blue Star Air Conditioning & Refrigeration (U) Limited, on 14th Oct'26. The entity has not commenced operations since its incorporation on 27th Jun'23, generating zero revenue and holding a negative net worth of AED 5,31,000 (approx. Rs 1.35 crore) as of 31st Mar'26. The strike-off process is targeted for completion on or before 31st Mar'27, subject to local regulatory clearances in Uganda.
BLUE STAR LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 29 Oct 2026, 5:30 am
Blue Star Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the Un-audited Standalone and Consolidated ....
Intimation · 29 Oct 2026, 5:30 am
Blue Star Schedules Board Meeting for Q2FY27 Results and Announces Trading Window Closure Blue Star Limited will hold a Board of Directors meeting on 29th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended 30th Sep'26. Additionally, in compliance with insider trading regulations, the trading window for designated persons will remain closed from 1st Oct'26 until 31st Oct'26 (both days inclusive).
Please find enclosed.
Intimation · 16 Sept 2026, 11:12 pm
Blue Star Schedules In-Person Institutional Investor Meetings in Sep'26 Blue Star Limited has scheduled in-person group meetings with institutional investors and analysts. The company will participate in the Anand Rathi annual flagship conference 2026 on 22nd Sep'26 from 10:00 am to 12:00 noon in Mumbai. Additionally, management will attend the J.P. Morgan India Consumption forum on 24th Sep'26 from 10:00 am to 11:00 am in Gurugram.
Please find enclosed.
Others (Uncategorized) · 15 Sept 2026, 10:44 pm
WJT Seeks Annulment of Favorable Arbitration Award Against Blue Star W.J. Towell & Co LLC (WJT) approached the Dubai Court of Appeal seeking the annulment of an ICC arbitration award issued in favor of Blue Star Limited on 23rd Jul'26, which dismissed WJT's entire claim of OMR 2,11,80,748 (~Rs 461.74 crore) related to Blue Star Oman Electro Mechanical Company. Blue Star stated that annulment proceedings do not reconsider the award's merits, deemed WJT's grounds baseless, and confirmed it will make appropriate submissions before the court. The company reiterated that this development has no material financial impact.
Please find enclosed.
Intimation · 04 Sept 2026, 10:57 pm
Blue Star Limited Schedules Institutional Investor Meetings in Sep'26 Blue Star Limited has scheduled two in-person group meetings with institutional investors and analysts. The company will participate in Axis Capital's Consumer & Tech conference on 10th Sep'26 from 10:00 am to 12:00 noon in Mumbai, followed by the Jefferies India Forum on 16th Sep'26 from 10:00 am to 1:00 pm in Gurugram.
Please find enclosed
Others (Uncategorized) · 02 Sept 2026, 10:23 pm
Blue Star Completes Sale of MedTech Business to Cyrix for Rs 40 Crores Blue Star completed the slump sale of its subsidiary's MedTech business to Cyrix Healthcare for up to Rs 40 crores in cash, effective 1st Sep'26. Consideration is payable in tranches, concluding 31st Mar'27. For the fiscal year ending 31st Mar'26, the divested MedTech division generated Rs 42.13 crores in revenue, representing 0.33% of Blue Star's consolidated income, and held a net worth of Rs 7.11 crores (0.21% of total). The transaction was executed to allow the company to refocus on its core strategic priorities.
Please find enclosed the intimation for execution of Business Transfer Agreement by a Subsidiary of the Company.
Others (Uncategorized) · 15 Aug 2026, 2:33 am
Blue Star Subsidiary Divests MedTech Division for Rs 40 Crore Blue Star's subsidiary, Blue Star E&E, has executed an agreement on 14 Aug'26 to divest its MedTech division to Cyrix Healthcare via a slump sale for up to Rs 40 crore. The division, which provides high-end medical diagnostic equipment, generated Rs 42.13 crore in revenue (0.33% of consolidated income) and had a net worth of Rs 7.11 crore (0.21% of consolidated) in FY26. The sale, driven by strategic priorities, is expected to be completed by 31 Mar'27. This transaction is not a related-party transaction.
Please find enclosed.
Transcript · 14 Aug 2026, 12:14 am
Please find enclosed.
Audio / Video · 07 Aug 2026, 11:01 pm
Blue Star Q1 FY27 Earnings Call Recording Made Public Blue Star Limited has published the audio recording of its investors' conference call, held to discuss the financial results for the first quarter ending on Jun 30, 2026. As per an intimation filed on Aug 7, 2026, the recording is now available on the company's website. This disclosure adheres to Regulations 30 and 46 of SEBI's Listing Regulations.
Please find enclosed intimation
Annual General Meeting · 07 Aug 2026, 9:35 pm
Blue Star Shareholders Approve All Resolutions at 78th AGM Blue Star announced that all resolutions at its 78th AGM on 06 Aug'26 were passed with requisite majority. Key approvals include the adoption of FY26 financial statements and a final dividend of ₹8.5 per share. However, the resolution to reappoint Director Rajiv R Lulla faced notable opposition, with 10.42% of public institutional votes against it, though it passed with 94.76% of total votes in favour. Overall voter turnout was 76.53%. All other resolutions were approved with near-unanimous support from all shareholder categories.